Form 4 for RLAY Relay Therapeutics, Inc.

Accepted 2023-09-29 00:00:00 ET · period of report 2023-09-27 · accession 0001209191-23-050866 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2023-09-29	2023-06-30	RLAY	Rahmer Peter	See remarks	A - Grant	$10.68	+1,662	319.8K	+0.5%	+$17.8K
	2023-09-29	2023-09-27	RLAY	Rahmer Peter	See remarks	S - Sale	$8.38	-244	318.2K	-0.1%	-$2,045

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-06-30	A	A	1,662	$10.68	319,822	D	—	—	(F2) In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 30, 2023. (F3) Includes 290,341 shares underlying restricted stock units ("RSUs").
2	Common	Common Stock	2023-09-27	S	D	244	$8.38	318,226	D	—	—	(F4) Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of RSUs on September 26, 2023. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. (F5) Prior to the reported transaction, the amount of securities beneficially owned by the reporting person was 318,470, with 284,835 shares underlying RSUs. (F6) Includes 283,843 shares underlying RSUs.